These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18364723)

  • 21. Interferon beta in the management of multiple sclerosis.
    Pender MP
    Aust N Z J Med; 1996 Jun; 26(3):343. PubMed ID: 8811205
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
    Dastgir J; DiMario FJ
    J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    Vandenbark AA; Huan J; Agotsch M; La Tocha D; Goelz S; Offner H; Lanker S; Bourdette D
    J Neuroimmunol; 2009 Oct; 215(1-2):125-8. PubMed ID: 19758707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pragmatic approach to treatments in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F125-31. PubMed ID: 19593885
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-interferon-induced nephrotic syndrome in a patient with multiple sclerosis.
    Gotsman I; Elhallel-Darnitski M; Friedlander Z; Haviv YS
    Clin Nephrol; 2000 Nov; 54(5):425-6. PubMed ID: 11105807
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis and pharmacological treatment of multiple sclerosis].
    Kleiter I; Steinbrecher A
    Fortschr Neurol Psychiatr; 2007 Jun; 75(6):363-71; quiz 372-4. PubMed ID: 17549661
    [No Abstract]   [Full Text] [Related]  

  • 29. Optic neuritis and risk of MS: differential diagnosis and management.
    Osborne BJ; Volpe NJ
    Cleve Clin J Med; 2009 Mar; 76(3):181-90. PubMed ID: 19258465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early multiple sclerosis: to treat or not to treat?
    Roach ES
    Arch Neurol; 2006 Apr; 63(4):619. PubMed ID: 16606782
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term experience with induction treatment regimens in multiple sclerosis.
    Le Page E; Edan G
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S46-9. PubMed ID: 19200867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes.
    Tintore M; Sastre-Garriga J
    Mult Scler; 2009 Apr; 15(4):407-8. PubMed ID: 19324977
    [No Abstract]   [Full Text] [Related]  

  • 33. [Beta-interferon will be transformed by Foldspang].
    Paulson OB
    Ugeskr Laeger; 1999 Jun; 161(26):4023-4. PubMed ID: 10402945
    [No Abstract]   [Full Text] [Related]  

  • 34. [Successful treatment of multiple sclerosis with beta-interferon].
    Rieckmann P; Gold R; Toyka K
    Internist (Berl); 1999 Jan; 40(1):119-25. PubMed ID: 10086315
    [No Abstract]   [Full Text] [Related]  

  • 35. [Safety and tolerability in the early phase of slow schedule versus fast schedule treatment with 44 micrograms of interferon beta-1a in patients with multiple sclerosis (PARALEN study)].
    Hernandez-Perez MA;
    Rev Neurol; 2009 May 16-31; 48(10):505-8. PubMed ID: 19434583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
    Moore F; Okuda DT
    Neurology; 2009 Nov; 73(20):1714. PubMed ID: 19918002
    [No Abstract]   [Full Text] [Related]  

  • 37. [Multiple sclerosis--symptoms, diagnosis and treatment].
    Elíasdóttir OJ; Olafsson E; Kjartansson O
    Laeknabladid; 2009 Sep; 95(9):583-9. PubMed ID: 19738293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord.
    Schirmer L; Albert M; Buss A; Schulz-Schaeffer WJ; Antel JP; Brück W; Stadelmann C
    Ann Neurol; 2009 Nov; 66(5):698-704. PubMed ID: 19938172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ; Cowan BJ; Hashimoto SA
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.